MYX vs NSB

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

MYX

M PHARMA FPO [MYX]

48LOW

NSB

NEUROSCIEN FPO [NSB]

48LOW

Score Breakdown

MYX NSB
Technical
78
36
Catalyst
87
50
Sentiment
50
50
Fundamental
87
70
Momentum
27
80
Risk Gate
45
46

Key Metrics

MYX Metric NSB
$189.7MMarket Cap$27.3M
599KAvg Volume (20d)221K
+2.9%Short InterestN/A
$7.29552-Week High$0.260
$2.04052-Week Low$0.034
+3.8%Daily Change+1.2%
$2.335Entry Price$0.083
-20.6%ROE-29.6%
-20.4%Profit MarginN/A

Active Signals

MYX Signals

●RSI drifting toward oversold territory — worth watching
●MACD just crossed bullish — momentum is shifting to the upside
●Volume surging at 2.8x normal while price climbs — real buying conviction behind this move
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (0.5x)
●EPS estimates revised upward (+10pts)

NSB Signals

●RSI drifting toward oversold territory — worth watching
●MACD crossed bearish — momentum is fading
●Trading below both moving averages — the trend is working against this one
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (18 quarters)
●4C filed 2026-01-29
●Very high P/S ratio (85.8x)
●Strong revenue growth (+129%)

Ask Scout AI to compare MYX and NSB in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
MYX Full Analysis → NSB Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).